The Marine Corps provided advanced notification on December 18th 2025 of changes to physical fitness standards. The new ...

MADISON, Wis., December 11, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results ...

Matthew Fisher is a right-arm fast-medium bowler who plays for Surrey and England Lions. The 28-year-old has been added to England's Test squad for the final three Tests of the Ashes after quick Mark ...

(This story was updated to add comment from Britton Tavern.) The man accused of killing a stranger in a popular Fishers bar has been charged with murder. At about 2:45 a.m. on Dec. 1, 2025, officers ...

FISHERS, Ind. – A Noblesville man died after a shooting inside a Fishers bar early Monday morning. Officers were dispatched to the 14000 block of Mundy Drive around 2:45 a.m. Monday. The address comes ...

FISHERS, Ind. — A Fishers woman admitted to police that she set a house on fire and stabbed herself. On Saturday, Fishers police and the Fishers Fire Department responded to a residential fire in the ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Shares of Exact Sciences (EXAS) continued to rise in the premarket on Thursday, adding ~18% after the cancer test maker agreed to be acquired by Abbott Laboratories (ABT) in an all-cash deal worth ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...